Nanogen, Inc Offers 6.8M Shares of Common Stock
Filed in archive Corporate and Industrial News on September 28, 2005

Nanogen, Inc. announced today that it will sell 6.8 million shares of its common stock to institutional investors at a price of $2.94 per share, plus 1.0 million warrants exercisable at $4.00 per share for five years.
Nanogen develops diagnostic tools and reagents for researchers, clinicians and physicians, such as real-time PCR reagents, the NanoChip(R) Molecular biology Workstation platform for molecular diagnostic applications and a line of rapid point-of-care diagnostic tests. Nanogen hopes to develop miniaturized diagnostic kits using nanotechnology.
Read nanogen's press release here. More on Nanogen stocks here.

Tags: diagnostics stocks biotech nanogen common common+stock shares+common nanogen+offers
Vote for Nanogen, Inc Offers 6.8M Shares of Common Stock:
|
Rating: 6.67 out of 3 vote(s) cast.
|
Response from:
David
(08/06/10 3:34am)
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells

_________________________________________________________
Money Stock